<110>    CUROGEN Technology Co., Ltd.
         Research and Business Foundation SUNGKYUNKWAN UNIVERSITY

<120>    Pharmaceutical composition for diagnosing, preventing or treating
         liver cnacer using Ssu72 protein or nucleotide coded thereof

<130>    PT22-5256

<150>    KR 10-2021-0008251
<151>    2021-01-20

<160>    3

<170>    KoPatentIn 3.0

<210>    1
<211>    194
<212>    PRT
<213>    Human Ssu72 protein sequence

<400>    1
Met Pro Ser Ser Pro Leu Arg Val Ala Val Val Cys Ser Ser Asn Gln
  1               5                  10                  15 

Asn Arg Ser Met Glu Ala His Asn Ile Leu Ser Lys Arg Gly Phe Ser
             20                  25                  30 

Val Arg Ser Phe Gly Thr Gly Thr His Val Lys Leu Pro Gly Pro Ala
         35                  40                  45 

Pro Asp Lys Pro Asn Val Tyr Asp Phe Lys Thr Thr Tyr Asp Gln Met
     50                  55                  60 

Tyr Asn Asp Leu Leu Arg Lys Asp Lys Glu Leu Tyr Thr Gln Asn Gly
 65                  70                  75                  80 

Ile Leu His Met Leu Asp Arg Asn Lys Arg Ile Lys Pro Arg Pro Glu
                 85                  90                  95 

Arg Phe Gln Asn Cys Lys Asp Leu Phe Asp Leu Ile Leu Thr Cys Glu
            100                 105                 110 

Glu Arg Val Tyr Asp Gln Val Val Glu Asp Leu Asn Ser Arg Glu Gln
        115                 120                 125 

Glu Thr Cys Gln Pro Val His Val Val Asn Val Asp Ile Gln Asp Asn
    130                 135                 140 

His Glu Glu Ala Thr Leu Gly Ala Phe Leu Ile Cys Glu Leu Cys Gln
145                 150                 155                 160 

Cys Ile Gln His Thr Glu Asp Met Glu Asn Glu Ile Asp Glu Leu Leu
                165                 170                 175 

Gln Glu Phe Glu Glu Lys Ser Gly Arg Thr Phe Leu His Thr Val Cys
            180                 185                 190 

Phe Tyr
       


<210>    2
<211>    585
<212>    DNA
<213>    Human Ssu72 gene sequence

<400>    2
atgccgtcgt ccccgctgcg ggtggcggtg gtgtgctcga gcaaccagaa ccggagcatg         60

gaggcgcaca acatcctcag caaacgggga ttcagcgtcc gatcctttgg aacagggact        120

cacgtgaagc ttccaggacc agctcccgac aagcccaatg tttatgattt caaaaccaca        180

tatgaccaga tgtacaatga tcttcttagg aaagacaaag aactctatac acagaatggg        240

attttacata tgctggacag aaataagaga atcaagcccc ggccagaaag attccagaac        300

tgcaaagacc tgtttgatct gatcctcact tgcgaagaga gagtgtatga ccaggtggtg        360

gaagatctga attccagaga acaggagacc tgccagcctg tgcacgtggt caatgtggac        420

atccaggaca accacgagga ggccaccctg ggggcgtttc tcatctgtga gctctgccag        480

tgtatccagc acacggaaga catggagaac gagatcgacg agctgctgca ggagttcgag        540

gagaagagtg gccgcacctt tctgcacacc gtctgcttct actga                        585


<210>    3
<211>    410
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    TBG promoter


<400>    3
tgcatgtata atttctacag aacctattag aaaggatcac ccagcctctg cttttgtaca         60

actttccctt aaaaaactgc caattccact gctgtttggc ccaatagtga gaactttttc        120

ctgctgcctc ttggtgcttt tgcctatggc ccctattctg cctgctgaag acactcttgc        180

cagcatggac ttaaacccct ccagctctga caatcctctt tctcttttgt tttacatgaa        240

gggtctggca gccaaagcaa tcactcaaag ttcaaacctt atcatttttt gctttgttcc        300

tcttggcctt ggttttgtac atcagctttg aaaataccat cccagggtta atgctggggt        360

taatttataa ctaagagtgc tctagttttg caatacagga catgctataa                   410
